XML 34 R21.htm IDEA: XBRL DOCUMENT
v3.23.2

Net Income Per Share | 6 Months Ended
--- | ---
Jun. 30, 2023
Earnings Per Share [Abstract] |
Net Income Per Share | Note 13. Net Income Per Share Basic weighted-average shares outstanding excludes nonvested restricted stock. Diluted weighted average shares outstanding is similar to basic weighted-average shares outstanding, except that the weighted-average number of shares is increased to include the number of additional common shares that would have been outstanding if the potentially dilutive common share had been issued, including the dilutive impact of nonvested restricted stock. Basic and diluted net income per share was calculated as follows:
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
﻿ |  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Basic net income per share |  | $ | 0.07 |  |  | $ | 0.09 |  |  | $ | 0.08 |  |  | $ | 0.18 |
Diluted net income per share |  | $ | 0.07 |  |  | $ | 0.09 |  |  | $ | 0.08 |  |  | $ | 0.18 |
Numerator: |  | ﻿ |  | ﻿ | ﻿ |  |  | ﻿ |  | ﻿ | ﻿ |
Net income (in thousands) |  | $ | 9,782 |  |  | $ | 14,236 |  |  | $ | 11,707 |  |  | $ | 27,249 |
Denominator: |  | ﻿ |  | ﻿ | ﻿ |  |  | ﻿ |  | ﻿ | ﻿ |
Weighted average number of shares outstanding - basic |  |  | 144,112,028 |  | ﻿ |  | 150,748,211 |  |  |  | 144,982,459 |  | ﻿ |  | 150,644,034 |
Add stock options to purchase shares and restricted stock units |  |  | 1,226,892 |  |  |  | 1,612,139 |  |  |  | 1,912,331 |  |  |  | 1,717,754 |
Weighted average number of shares outstanding - diluted |  |  | 145,338,920 |  |  |  | 152,360,350 |  |  |  | 146,894,790 |  |  |  | 152,361,788 |
For the three months ended June 30, 2023 and 2022, 4,961,441 and 2,533,594 stock options and RSUs were excluded from the calculation of diluted net income per share, respectively, because their effects were anti-dilutive. For the six months ended June 30, 2023 and 2022, 4,681,847 and 2,292,520 stock options and RSUs were excluded from the calculation of diluted net income per share, respectively, because their effects were anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration